Zeolitic Imidazolate Framework (ZIF-8) Decorated Iron Oxide Nanoparticles Loaded Doxorubicin Hydrochloride for Osteosarcoma Treatment - in vitro and in vivo Preclinical Studies

References

• Marchandet L, Lallier M, Charrier C, Baud’huin M, Ory B, Lamoureux F. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma. Cancers. 2021;13(4):683. doi:10.3390/cancers13040683
   PubMed Web of Science ®Google Scholar
• Smrke A, Anderson PM, Gulia A, Gennatas S, Huang PH, Jones RL. Future Directions in the Treatment of Osteosarcoma. Cells. 2021;10(1):172. doi:10.3390/cells10010172
   PubMed Web of Science ®Google Scholar
• Gill J, Ahluwalia MK, Geller D, Gorlick R. New targets and approaches in osteosarcoma. Pharmacol Ther. 2013;137(1):89–99. doi:10.1016/j.pharmthera.2012.09.003
   PubMed Web of Science ®Google Scholar
• Chou AJ, Gorlick R. Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Rev Anticancer Ther. 2006;6(7):1075–1085. doi:10.1586/14737140.6.7.1075
   PubMed Web of Science ®Google Scholar
• Gorlick R. Current concepts on the molecular biology of osteosarcoma. Cancer Treatment Res. 2009;152:467–478.
   PubMedGoogle Scholar
• Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018;18(1):39–50. doi:10.1080/14737140.2018.1413939
   PubMed Web of Science ®Google Scholar
• Ferrari S, Serra M. An update on chemotherapy for osteosarcoma. Exp Opinion Pharmacother. 2015;16(18):2727–2736. doi:10.1517/14656566.2015.1102226
   PubMed Web of Science ®Google Scholar
• Carvalho C, Santos RX, Cardoso S, et al. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 2009;16(25):3267–3285. doi:10.2174/092986709788803312
   PubMed Web of Science ®Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–124. doi:10.1038/s41573-020-0090-8
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang F, Li M, et al. Self-Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma. Adv Sci. 2018;5(5):1700821. doi:10.1002/advs.201700821
   Web of Science ®Google Scholar
• Rahmani E, Pourmadadi M, Ghorbanian SA, Yazdian F, Rashedi H, Navaee M. Preparation of a pH-responsive chitosan-montmorillonite-nitrogen-doped carbon quantum dots nanocarrier for attenuating doxorubicin limitations in cancer therapy. Eng Life Sci. 2022;22(10):634–649. doi:10.1002/elsc.202200016
   PubMed Web of Science ®Google Scholar
• Wei H, Chen J, Wang S, et al. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro. Int J Nanomed. 2019;14:8603–8610. doi:10.2147/IJN.S218988
   PubMed Web of Science ®Google Scholar
• Feng Y, Gao Y, Wang D, Xu Z, Sun W, Ren P. Autophagy Inhibitor (LY294002) and 5-fluorouracil (5-FU) Combination-Based Nanoliposome for Enhanced Efficacy Against Esophageal Squamous Cell Carcinoma. Nanoscale Res Lett. 2018;13(1):325. doi:10.1186/s11671-018-2716-x
   PubMed Web of Science ®Google Scholar
• Wang X, Yang FF, Zhang LP, Huang YP, Liu ZS. A polyhedral oligomeric silsesquioxane/molecular sieve codoped molecularly imprinted polymer for gastroretentive drug-controlled release in vivo. Biomater Sci. 2018;6(12):3170–3177. doi:10.1039/C8BM01124A
   PubMed Web of Science ®Google Scholar
• Zhou ZF, Sun TW, Chen F, et al. Calcium phosphate-phosphorylated adenosine hybrid microspheres for anti-osteosarcoma drug delivery and osteogenic differentiation. Biomaterials. 2017;121:1–14. doi:10.1016/j.biomaterials.2016.12.031
   PubMed Web of Science ®Google Scholar
• Liu Y, Jiang Z, Tong S, et al. Acidity-Triggered Transformable Polypeptide Self-Assembly to Initiate Tumor-Specific Biomineralization. Adv Materials. 2023;35(15):56.
   Web of Science ®Google Scholar
• Chai Z, Hu X, Wei X, et al. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J Controlled Release. 2017;264:102–111. doi:10.1016/j.jconrel.2017.08.027
   PubMed Web of Science ®Google Scholar
• Wu MX, Yang YW. Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy. Adv Materials. 2017;29(23). doi:10.1002/adma.201606134
   Web of Science ®Google Scholar
• Ahmadi M, Ebrahimnia M, Shahbazi MA, Kecili R, Ghorbani-Bidkorbeh F. Microporous metal-organic frameworks: synthesis and applications. J Ind Eng Chem. 2022;115:1–11. doi:10.1016/j.jiec.2022.07.047
   Web of Science ®Google Scholar
• Yin M, Wu J, Deng M, et al. Multifunctional Magnesium Organic Framework-Based Microneedle Patch for Accelerating Diabetic Wound Healing. ACS nano. 2021;15(11):17842–17853. doi:10.1021/acsnano.1c06036
   PubMed Web of Science ®Google Scholar
• Qiao C, Zhang R, Wang Y, et al. Rabies Virus-Inspired Metal-Organic Frameworks (MOFs) for Targeted Imaging and Chemotherapy of Glioma. Angewandte Chemie. 2020;59(39):16982–16988. doi:10.1002/anie.202007474
   Google Scholar
• Qiang S, Hu X, Li R, et al. CuS Nanoparticles-Loaded and Cisplatin Prodrug Conjugated Fe(III)-MOFs for MRI-Guided Combination of Chemotherapy and NIR-II Photothermal Therapy. ACS Appl. Mater. Interfaces. 2022;14(32):36503–36514. doi:10.1021/acsami.2c12727
   PubMed Web of Science ®Google Scholar
• Guo L, Zhong S, Liu P, Guo M, Ding J, Zhou W. Radicals Scavenging MOFs Enabling Targeting Delivery of siRNA for Rheumatoid Arthritis Therapy. Small. 2022;18(27):e2202604. doi:10.1002/smll.202202604
   PubMed Web of Science ®Google Scholar
• Huo Q, Liang Y, Lu W, et al. Integrated Metalloproteinase, pH and Glutathione Responsive Prodrug-Based Nanomedicine for Efficient Target Chemotherapy. J Biomed Nanotechnol. 2019;15(8):1673–1687. doi:10.1166/jbn.2019.2801
   PubMed Web of Science ®Google Scholar
• Cai W, Zhang W, Chen Z. Magnetic Fe(3)O(4)@ZIF-8 nanoparticles as a drug release vehicle: pH-sensitive release of norfloxacin and its antibacterial activity. Colloids Surf B. 2023;223:113170. doi:10.1016/j.colsurfb.2023.113170
   PubMed Web of Science ®Google Scholar
• Abdelhamid HN. Zeolitic Imidazolate Frameworks (ZIF-8) for Biomedical Applications: a Review. Curr Med Chem. 2021;28(34):7023–7075. doi:10.2174/0929867328666210608143703
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang Z, Qiu D, et al. LnNP@ZIF8 Smart System for In Situ NIR-II Ratiometric Imaging-Based Tumor Drug Resistance Evaluation. Nanomaterials. 2022;12(24):4478. doi:10.3390/nano12244478
   Web of Science ®Google Scholar
• Liang Z, Yang Z, Yuan H, et al. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery. Dalton Trans 2018;47(30):10223–10228. doi:10.1039/C8DT01789A
   PubMed Web of Science ®Google Scholar
• Xuan S, Wang Y-XJ, Yu JC, Leung KC-F. Tuning the Grain Size and Particle Size of Superparamagnetic Fe3O4 Microparticles. Chem Mater 2009;21(21):5079–5087. doi:10.1021/cm901618m
   Web of Science ®Google Scholar
• Chen GH, Yu B, Lu CH, Zhang HH, Shen YQ, Cong HL. Controlled synthesis of Fe3O4@ZIF-8 nanoparticles for drug delivery. Crystengcomm. 2018;20(46):7486–7491. doi:10.1039/C8CE01302K
   Web of Science ®Google Scholar
• Wu Q, Wang D, Chen C, Peng C, Cai D, Wu Z. Fabrication of Fe3O4/ZIF-8 nanocomposite for simultaneous removal of copper and arsenic from water/soil/swine urine. J Environ Manage. 2021;290:112626. doi:10.1016/j.jenvman.2021.112626
   PubMedGoogle Scholar
• Jiang X, Su S, Rao JT, et al. Magnetic metal-organic framework (Fe3O4@ZIF-8) core-shell composite for the efficient removal of Pb(II) and Cu(II) from water. J Environ Chem Eng. 2021;9(5):105959. doi:10.1016/j.jece.2021.105959
   Web of Science ®Google Scholar
• Huang X, Liu Y, Wang X, et al. Removal of Arsenic from Wastewater by Using Nano Fe(3)O(4)/Zinc Organic Frameworks. Int J Environ Res Public Health. 2022;19(17):85.
   Web of Science ®Google Scholar
• Al-Hazmi GH, Adam AMA, El-Desouky MG, El-Bindary AA, Alsuhaibani AM, Refat MS. Efficient Adsorption Of Rhodamine B Using A Composite Of Fe3o4@Zif-8: synthesis, Characterization, Modeling Analysis, Statistical Physics And Mechanism Of Interaction. Bull Chem Soc Ethiop 2023;37(1):211–229. doi:10.4314/bcse.v37i1.17
   Web of Science ®Google Scholar
• Esfahanian M, Ghasemzadeh MA, Razavian SMH. Synthesis, identification and application of the novel metal-organic framework Fe(3)O(4)@PAA@ZIF-8 for the drug delivery of ciprofloxacin and investigation of antibacterial activity. Artif Cells Nanomed Biotechnol 2019;47(1):2024–2030. doi:10.1080/21691401.2019.1617729
   PubMed Web of Science ®Google Scholar
• Wang P, Wang GY, Tang HW, et al. Preparation of Ropivacaine Encapsulated by Zeolite Imidazole Framework Microspheres as Sustained-Release System and Efficacy Evaluation. Chemistry. 2023.
   PubMed Web of Science ®Google Scholar
• Zhang M, Gao YY, Han LM, Zhu N, Gao XC. The construction of a multifunctional metal-organic framework for targeting tumors and bioimaging. New J Chem. 2020;44(42):18303–18307. doi:10.1039/D0NJ04463F
   Web of Science ®Google Scholar
• Schejn A, Mazet T, Falk V, et al. Fe3O4@ZIF-8: magnetically recoverable catalysts by loading Fe3O4 nanoparticles inside a zinc imidazolate framework. Dalton Trans. 2015;44(22):10136–10140. doi:10.1039/C5DT01191D
   PubMed Web of Science ®Google Scholar
• Sun CY, Qin C, Wang XL, et al. Zeolitic Imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle. Dalton Trans. 2012;41(23):6906–6909. doi:10.1039/c2dt30357d
   PubMed Web of Science ®Google Scholar
• Zhang XM, Jiang JH, Yu QH, et al. ZIF-based carbon dots with lysosome-Golgi transport property as visualization platform for deep tumour therapy via hierarchical size/charge dual-transform and transcytosis. Nanoscale. 2022;14(23):8510–8524. doi:10.1039/D2NR02134J
   PubMed Web of Science ®Google Scholar
• Li M, Yue XF, Wang Y, Zhang J, Kan LW, Jing ZW. Remodeling the tumor microenvironment to improve drug permeation and antitumor effects by co-delivering quercetin and doxorubicin. J Mat Chem B. 2019;7(47):7619–7626. doi:10.1039/C9TB02131K
   PubMed Web of Science ®Google Scholar
• Xie RH, Yang P, Peng SJ, et al. A phosphorylcholine-based zwitterionic copolymer coated ZIF-8 nanodrug with a long circulation time and charged conversion for enhanced chemotherapy. J Mat Chem B. 2020;8(28):6128–6138. doi:10.1039/D0TB00193G
   PubMed Web of Science ®Google Scholar
• Lin Y, Zhong Y, Chen Y, et al. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy. Mol Pharmaceut. 2020;17(9):3328–3341. doi:10.1021/acs.molpharmaceut.0c00421
   PubMed Web of Science ®Google Scholar
• Li JH, Zhu DM, Ma WJ, et al. Rapid synthesis of a Bi@ZIF-8 composite nanomaterial as a near-infrared-II (NIR-II) photothermal agent for the low-temperature photothermal therapy of hepatocellular carcinoma. Nanoscale. 2020;12(32):17064–17073. doi:10.1039/D0NR03907A
   PubMed Web of Science ®Google Scholar
• Jiang Z, Li Y, Wei Z, et al. Pressure-induced amorphous zeolitic imidazole frameworks with reduced toxicity and increased tumor accumulation improves therapeutic efficacy In vivo. Bioact Mater. 2021;6(3):740–748. doi:10.1016/j.bioactmat.2020.08.036
   PubMed Web of Science ®Google Scholar
• Guan YX, Yang YX, Wang XX, et al. Multifunctional Fe3O4@SiO2-CDs magnetic fluorescent nanoparticles as effective carrier of gambogic acid for inhibiting VX2 tumor cells. J Mol Liq. 2021;327.
   Web of Science ®Google Scholar
• Cheng C, Li C, Zhu X, Han W, Li J, Lv Y. Doxorubicin-loaded Fe(3)O(4)-ZIF-8 nano-composites for hepatocellular carcinoma therapy. J Biomaterials Appl. 2019;33(10):1373–1381. doi:10.1177/0885328219836540
   PubMed Web of Science ®Google Scholar
• Chen XR, Shi ZQ, Tong RL, et al. Derivative of Epigallocatechin-3-gallatea Encapsulated in ZIF-8 with Polyethylene Glycol-Folic Acid Modification for Target and pH-Responsive Drug Release in Anticancer Research. ACS Biomater Sci Eng. 2018;4(12):4183–4192. doi:10.1021/acsbiomaterials.8b00840
   PubMed Web of Science ®Google Scholar
• Shi Y, van der Meel R, Chen X, Lammers T. The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. Theranostics. 2020;10(17):7921–7924. doi:10.7150/thno.49577
   PubMed Web of Science ®Google Scholar
• Fang J, Islam W, Maeda H. Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers. Adv Drug Delivery Rev 2020;157:142–160. doi:10.1016/j.addr.2020.06.005
   PubMed Web of Science ®Google Scholar
• Kent CA, Mehl BP, Ma L, Papanikolas JM, Meyer TJ, Lin W. Energy transfer dynamics in metal-organic frameworks. J Am Chem Soc. 2010;132(37):12767–12769. doi:10.1021/ja102804s
   PubMed Web of Science ®Google Scholar
• Avci C, Ariñez-Soriano J, Carné-Sánchez A, et al. Post-Synthetic Anisotropic Wet-Chemical Etching of Colloidal Sodalite ZIF Crystals. Angewandte Chemie. 2015;54(48):14417–14421. doi:10.1002/anie.201507588
   Google Scholar
• Padhye P, Alam A, Ghorai S, Chattopadhyay S, Poddar P. Doxorubicin-conjugated β-NaYF4:Gd(3+)/Tb(3+) multifunctional, phosphor nanorods: a multi-modal, luminescent, magnetic probe for simultaneous optical and magnetic resonance imaging and an excellent pH-triggered anti-cancer drug delivery nanovehicle. Nanoscale. 2015;7(46):19501–19518. doi:10.1039/C5NR04473A
   PubMed Web of Science ®Google Scholar
• Adhikari C, Das A, Chakraborty A. Zeolitic Imidazole Framework (ZIF) Nanospheres for Easy Encapsulation and Controlled Release of an Anticancer Drug Doxorubicin under Different External Stimuli: a Way toward Smart Drug Delivery System. Mol Pharmaceut. 2015;12(9):3158–3166. doi:10.1021/acs.molpharmaceut.5b00043
   PubMed Web of Science ®Google Scholar
• Li X, Hou S, Chen J, et al. Engineering silk sericin decorated zeolitic imidazolate framework-8 nanoplatform to enhance chemotherapy. Colloids Surf B. 2021;200:111594. doi:10.1016/j.colsurfb.2021.111594
   PubMed Web of Science ®Google Scholar
• Wang Z, Niu J, Zhao C, Wang X, Ren J, Qu X. A Bimetallic Metal-Organic Framework Encapsulated with DNAzyme for Intracellular Drug Synthesis and Self-Sufficient Gene Therapy. Angewandte Chemie. 2021;60(22):12431–12437. doi:10.1002/anie.202016442
   Google Scholar
• Xu M, Hu Y, Ding W, et al. Rationally designed rapamycin-encapsulated ZIF-8 nanosystem for overcoming chemotherapy resistance. Biomaterials. 2020;258:120308. doi:10.1016/j.biomaterials.2020.120308
   PubMed Web of Science ®Google Scholar
• Wang J, Chen P, Dong Y, et al. Designer exosomes enabling tumor targeted efficient chemo/gene/photothermal therapy. Biomaterials. 2021;276:121056. doi:10.1016/j.biomaterials.2021.121056
   PubMed Web of Science ®Google Scholar
• Sun XK, Dong B, Xu HW, et al. Amphiphilic Silane Modified Multifunctional Nanoparticles for Magnetically Targeted Photodynamic Therapy. ACS Appl Mater Interfaces. 2017;9(13):11451–11460. doi:10.1021/acsami.7b00647
   PubMed Web of Science ®Google Scholar
• Guo XM, Li W, Luo LH, et al. External Magnetic Field-Enhanced Chemo-Photothermal Combination Tumor Therapy via Iron Oxide Nanoparticles. ACS Appl Mater Interfaces. 2017;9(19):16581–16593. doi:10.1021/acsami.6b16513
   PubMed Web of Science ®Google Scholar
• Dada SN, Babanyinah GK, Tetteh MT, et al. Covalent and Noncovalent Loading of Doxorubicin by Folic Acid-Carbon Dot Nanoparticles for Cancer Theranostics. ACS omega. 2022;7(27):23322–23331. doi:10.1021/acsomega.2c01482
   PubMed Web of Science ®Google Scholar
• Tian Y, Li S, Song J, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014;35(7):2383–2390. doi:10.1016/j.biomaterials.2013.11.083
   PubMed Web of Science ®Google Scholar